A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
Clinical trial NCT05677659 · TERMINATED
Trial details
- NCT number
- NCT05677659
- Sponsor
- Vigil Neuroscience, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2025-02-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.